Mylotarg Injection, Powder, Lyophilized, For Solution
Product Images NDC 0008-4510

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Mylotarg (NDC 0008-4510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mylotarg 01)

Gemtuzumab is a medication that contains an ingredient called N-Acetyl Calicheamicin. The average dosage is 2-3, but any additional information is not available due to incomplete text.*

FDA Label Image

Figure 1 (Mylotarg 02)

FDA Label Image

Figure 2 (Mylotarg 03)

FDA Label Image

Logo (Mylotarg 04)

This is a description of the manufacturer of a product. The product is manufactured by Wyeth Pharmaceuticals LLC, which is a subsidiary of Pizer Inc located in Philadelphia, PA 19101.*

FDA Label Image

Principal Display Panel (4.5 mg Vial Label)

FDA Label Image

Principal Display Panel (4.5 mg Vial Carton)

This document contains information about MYLOTARG, a medication used for Intravenous Infusion. The document provides information about the dosage, usage, refrigeration and reconstitution methods required for MYLOTARG. However, the document also contains errors and missing characters, creating ambiguities and making the text largely unreadable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.